Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001641172-25-020519
Filing Date
2025-07-22
Accepted
2025-07-22 08:00:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 form424b5.htm 424B5 10495
2 GRAPHIC form424b5_001.jpg GRAPHIC 9436
  Complete submission text file 0001641172-25-020519.txt   24936
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279425 | Film No.: 251138706
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)